Amicus Therapeutics, Inc. is a global biotechnology company that is committed to discovering, developing, and delivering innovative medicines for people with rare diseases. They are participating in a fireside chat at the Bank of America 2024 Health Care Conference in Las Vegas, NV on Wednesday, May 15, 2024, at 1:40 p.m. P.T.
Amicus Therapeutics has a strong focus on the patient and is dedicated to expanding and advancing their pipeline of cutting-edge medicines for rare diseases. For more information about their mission and programs, visit their website at www.amicusrx.com or follow them on X and LinkedIn.
For investor inquiries, contact Andrew Faughnan, Vice President of Investor Relations at afaughnan@amicusrx.com or (609) 662-3809. For media inquiries, contact Diana Moore, Head of Global Corporate Affairs and Communications at dmoore@amicusrx.com or (609) 662-5079
